Carbapenems are antimicrobials used for the treatment of serious infections in humans. Resistance of bacteria to carbapenems poses a public health risk as it could leave few available therapeutic options for patients. To date, only a few studies have reported carbapenem-resistant bacteria in food-producing animals. Experts in EFSA’s Panel on Biological Hazards (BIOHAZ) have assessed the potential for resistance transmission from animals to humans through the food chain. The scientific opinion also gives recommendation on how to prevent the emergence of resistant bacteria.